Downregulation of TOP2 modulates neurodegeneration caused by GGGGCC expanded repeats.

GGGGCC repeats in a non-coding region of the C9orf72 gene have been identified as a major genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. We previously showed that the GGGGCC expanded repeats alone were sufficient to cause neurodegeneration in Drosophila. Recent evidence indicates that GGGGCC expanded repeats can modify various gene transcriptomes. To determine the role of these genes in GGGGCC-mediated neurotoxicity, we screened an established Drosophila model expressing GGGGCC expanded repeats in this study. Our results showed that knockdown of the DNA topoisomerase II (Top2) gene can specifically modulate GGGGCC-associated neurodegeneration of the eye. Furthermore, chemical inhibition of Top2 or siRNA-induced Top2 downregulation could alleviate the GGGGCC-mediated neurotoxicity in Drosophila assessed by eye neurodegeneration and locomotion impairment. By contrast, upregulated Top2 levels were detected in Drosophila strains, and moreover, TOP2A level was also upregulated in Neuro-2a cells expressing GGGGCC expanded repeats, as well as in the brains of Sod1G93A model mice. This indicated that elevated levels of TOP2A may be involved in a pathway common to the pathophysiology of distinct ALS forms. Moreover, through RNA-sequencing, a total of 67 genes, involved in the pathways of intracellular signaling cascades, peripheral nervous system development, et al, were identified as potential targets of TOP2A to modulate GGGGCC-mediated neurodegeneration.

[1]  O. Bouchez,et al.  Transcription-associated topoisomerase activities control DNA-breaks production by G-quadruplex ligands , 2020, bioRxiv.

[2]  Ž. Skok,et al.  Dual inhibitors of human DNA topoisomerase II and other cancer-related targets. , 2020, Journal of medicinal chemistry.

[3]  M. Kiaei,et al.  Profilin1 biology and its mutation, actin(g) in disease , 2016, Cellular and Molecular Life Sciences.

[4]  M. Cazzaniga,et al.  Benefit of low‐dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS , 2016, International journal of cancer.

[5]  Eric W. Danielson,et al.  Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity , 2016, Proceedings of the National Academy of Sciences.

[6]  B. Patel,et al.  Poster 280 ALS Masked by Breast Cancer History and Low Back Pain: A Case Report , 2016, PM & R : the journal of injury, function, and rehabilitation.

[7]  Mackenzie W. Mathis,et al.  ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks , 2016, Nature Neuroscience.

[8]  Jian Jin,et al.  Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation , 2016, Science.

[9]  G. Sobue,et al.  Amyotrophic lateral sclerosis and motor neuron syndromes in Asia , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  Sean J. Miller,et al.  The C9orf72 repeat expansion disrupts nucleocytoplasmic transport , 2015, Nature.

[11]  Markus Weber,et al.  Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS , 2015, Molecular Neurodegeneration.

[12]  Christian A. Ross,et al.  Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS , 2015, Nature Neuroscience.

[13]  Stuart A. Wilson,et al.  Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions , 2014, Brain : a journal of neurology.

[14]  L. Petrucelli,et al.  Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.

[15]  E. Kremmer,et al.  Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins , 2013, Acta Neuropathologica.

[16]  W. Le,et al.  Genetics of amyotrophic lateral sclerosis: an update , 2013, Molecular Neurodegeneration.

[17]  M. Dowsett,et al.  Biomarkers for the clinical management of breast cancer: International perspective , 2013, International journal of cancer.

[18]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[19]  Chadwick M. Hales,et al.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration , 2013, Proceedings of the National Academy of Sciences.

[20]  E. Kremmer,et al.  The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.

[21]  M. Swash,et al.  Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.

[22]  Kevin F. Bieniek,et al.  Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.

[23]  Hao Wu,et al.  A new shrinkage estimator for dispersion improves differential expression detection in RNA-seq data , 2012, Biostatistics.

[24]  K. Tsai,et al.  Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43 , 2012, Proceedings of the National Academy of Sciences.

[25]  Gene W. Yeo,et al.  Misregulated RNA processing in amyotrophic lateral sclerosis , 2012, Brain Research.

[26]  Lukas Burger,et al.  Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state , 2012, Proceedings of the National Academy of Sciences.

[27]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[28]  S. Pereson,et al.  A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.

[29]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[30]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[31]  A. Aguilera,et al.  Topological constraints impair RNA polymerase II transcription and causes instability of plasmid-borne convergent genes , 2011, Nucleic acids research.

[32]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[33]  Holger Sültmann,et al.  ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction , 2010, Clinical Cancer Research.

[34]  J. Landers,et al.  RNA processing pathways in amyotrophic lateral sclerosis , 2010, neurogenetics.

[35]  W. Tourtellotte,et al.  Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice , 2008, Development.

[36]  A. Wells,et al.  Profilin-1 is a negative regulator of mammary carcinoma aggressiveness , 2007, British Journal of Cancer.

[37]  G. Sobue,et al.  [Gene expression profile of spinal ventral horn in ALS]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.

[38]  G. Sobue,et al.  Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis , 2005, Annals of neurology.

[39]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[40]  M. Mattern,et al.  Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  W. Earnshaw,et al.  Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.